WHO ICTRP trial
A study to find out the effect and safety of Amlapitta Mishran Suspension in…
CTRI/2020/02/023224 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2020/02/023224 |
|---|---|
| Public title | A study to find out the effect and safety of Amlapitta Mishran Suspension in patients with gastritis (stomach inflammation). |
| Scientific title | A prospective, single centre, open label, single arm study to Evaluate the Efficacy and Safety of Amlapitta Mishran Suspension in Participants with Endoscopic Gastritis. |
| Primary sponsor | Shree Dhootapapeshwar Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: K297- Gastritis, unspecified |
| Interventions | Intervention1: Amlapitta Mishran Suspension: Amlapitta Mishran 15 ml suspension orally before meals twice daily for 30 days. Ayurved Proprietary Medicine containing Shouktik Bhasma (Processed Shell) and herbs like Vasa (Adhatoda vasica)… |
| Registration date | Oct 2, 2020 |
| Target size | 30 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: